$SIGA
SIGA TECHNOLOGIES INC

2012 Q2 Form 10-Q Financial Statement

#000101008612000014 Filed on August 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue $2.700M $2.500M
YoY Change 8.0% -43.18%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.475M $9.351M
YoY Change -62.84% 325.05%
% of Gross Profit
Research & Development $5.183M $3.835M
YoY Change 35.15% -21.73%
% of Gross Profit
Depreciation & Amortization $110.0K $180.0K
YoY Change -38.89% 5.88%
% of Gross Profit
Operating Expenses $9.034M $13.60M
YoY Change -33.57% 81.32%
Operating Profit -$6.332M -$11.11M
YoY Change -43.0%
Interest Expense $0.00 $2.000M
YoY Change -100.0% -190.91%
% of Operating Profit
Other Income/Expense, Net $74.00 $2.006K
YoY Change -96.31%
Pretax Income -$5.428M -$9.066M
YoY Change -40.13% 71.06%
Income Tax -$1.661M -$32.91M
% Of Pretax Income
Net Earnings -$3.767M $23.84M
YoY Change -115.8% -549.85%
Net Earnings / Revenue -139.52% 953.68%
Basic Earnings Per Share -$0.08 $0.47
Diluted Earnings Per Share -$0.08 $0.44
COMMON SHARES
Basic Shares Outstanding 51.64M shares 50.88M shares
Diluted Shares Outstanding 51.64M shares 54.67M shares

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.90M $15.00M
YoY Change 132.67% -1.96%
Cash & Equivalents $34.93M $5.000M
Short-Term Investments $10.00M
Other Short-Term Assets $1.200M $400.0K
YoY Change 200.0% -33.33%
Inventory $8.860M
Prepaid Expenses $542.1K
Receivables $1.518M $1.800M
Other Receivables $0.00 $0.00
Total Short-Term Assets $46.58M $17.20M
YoY Change 170.81% -10.88%
LONG-TERM ASSETS
Property, Plant & Equipment $855.2K $900.0K
YoY Change -4.98% -47.06%
Goodwill $898.3K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.626M $32.90M
YoY Change -95.06% 10866.67%
Total Long-Term Assets $46.06M $34.80M
YoY Change 32.36% 1100.0%
TOTAL ASSETS
Total Short-Term Assets $46.58M $17.20M
Total Long-Term Assets $46.06M $34.80M
Total Assets $92.64M $52.00M
YoY Change 78.16% 134.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.05M $1.400M
YoY Change 617.56% -68.18%
Accrued Expenses $4.465M $1.900M
YoY Change 135.02% 171.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.51M $3.200M
YoY Change 353.48% -67.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $43.90M $5.800M
YoY Change 656.9% -55.38%
Total Long-Term Liabilities $43.90M $5.800M
YoY Change 656.9% -55.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.51M $3.200M
Total Long-Term Liabilities $43.90M $5.800M
Total Liabilities $58.40M $9.000M
YoY Change 548.84% -60.7%
SHAREHOLDERS EQUITY
Retained Earnings -$117.3M
YoY Change
Common Stock $151.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.25M $42.90M
YoY Change
Total Liabilities & Shareholders Equity $92.64M $52.00M
YoY Change 78.16% 134.23%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income -$3.767M $23.84M
YoY Change -115.8% -549.85%
Depreciation, Depletion And Amortization $110.0K $180.0K
YoY Change -38.89% 5.88%
Cash From Operating Activities -$6.240M -$4.460M
YoY Change 39.91% 187.74%
INVESTING ACTIVITIES
Capital Expenditures -$70.00K -$60.00K
YoY Change 16.67% -89.29%
Acquisitions
YoY Change
Other Investing Activities -$1.350M $5.000M
YoY Change -127.0%
Cash From Investing Activities -$1.410M $4.950M
YoY Change -128.48% -1000.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 660.0K
YoY Change -100.0% 371.43%
NET CHANGE
Cash From Operating Activities -6.240M -4.460M
Cash From Investing Activities -1.410M 4.950M
Cash From Financing Activities 0.000 660.0K
Net Change In Cash -7.650M 1.150M
YoY Change -765.22% -158.67%
FREE CASH FLOW
Cash From Operating Activities -$6.240M -$4.460M
Capital Expenditures -$70.00K -$60.00K
Free Cash Flow -$6.170M -$4.400M
YoY Change 40.23% 344.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
2000983 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
10045821 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2278316 USD
CY2011Q4 us-gaap Accounts Receivable Billed For Long Term Contracts Or Programs
AccountsReceivableBilledForLongTermContractsOrPrograms
0 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2637103 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1517947 USD
CY2011Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1067000 USD
CY2012Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
838643 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4644461 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4465450 USD
CY2012Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
665778 USD
CY2011Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
339200 USD
CY2012Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
310775 USD
us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2011Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
222706 USD
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
151509784 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
150551211 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8300000 USD
CY2012Q2 us-gaap Assets
Assets
92640990 USD
CY2011Q4 us-gaap Assets
Assets
90380477 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
46578955 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
52978703 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34932776 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49256930 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5000364 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6332053 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14324154 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1331689 USD
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51637352 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
51638352 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51637352 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51638352 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
5164 USD
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
5164 USD
CY2012Q2 us-gaap Deferred Costs
DeferredCosts
1937671 USD
CY2011Q4 us-gaap Deferred Costs
DeferredCosts
250072 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3593439 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-32895528 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
41001110 USD
CY2012Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
42992609 USD
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
35900000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
39500000 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
726203 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
727772 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
35149031 USD
CY2012Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
38744039 USD
CY2012Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
5200000 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4600000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
347314 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
208973 USD
CY2011Q2 us-gaap Dilutive Securities
DilutiveSecurities
-2039851 USD
CY2012Q2 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
us-gaap Dilutive Securities
DilutiveSecurities
-3802809 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1991499 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2011Q4 us-gaap Goodwill
Goodwill
898334 USD
CY2012Q2 us-gaap Goodwill
Goodwill
898334 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6007277 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11992889 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13754449 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9066062 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3593439 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32895101 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-32907988 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1660720 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1015153 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7588494 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
881827 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1193504 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
0 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
7572 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
1687599 USD
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8859970 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
960 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7501 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
20925 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9596 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3842 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
185161 USD
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
4085824 shares
CY2011Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3791804 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2012Q2 us-gaap Inventory Net
InventoryNet
8859970 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
0 USD
CY2012Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
8900000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
48694411 USD
CY2012Q2 us-gaap Liabilities
Liabilities
58395801 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
92640990 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
90380477 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
14511271 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6922777 USD
CY2012Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
2422103 USD
CY2011Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
2050000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2513462 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1690 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4911690 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1593145 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8756841 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12732699 USD
us-gaap Net Income Loss
NetIncomeLoss
-8399450 USD
us-gaap Net Income Loss
NetIncomeLoss
19140652 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-4346557 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
23841926 USD
CY2011Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
21802075 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-8399450 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-4346557 USD
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
15337843 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2006 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12100 USD
CY2011Q2 siga Patent Preparation Fees
PatentPreparationFees
413048 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
74 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
236 USD
CY2011Q2 us-gaap Operating Expenses
OperatingExpenses
13598975 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
9033527 USD
us-gaap Operating Expenses
OperatingExpenses
21757135 USD
us-gaap Operating Expenses
OperatingExpenses
16048240 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17569358 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11881324 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-11107919 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6332363 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
965555 USD
CY2012Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
228151 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1625800 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
285345 USD
CY2012Q2 us-gaap Other Liabilities
OtherLiabilities
157182 USD
CY2011Q4 us-gaap Other Liabilities
OtherLiabilities
147586 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1093936 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
245189 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95382 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
24992928 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2012Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
542059 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
356898 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
30000000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
0 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
855208 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
818992 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5182516 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7401664 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3835386 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9647054 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117269759 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108870309 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9350541 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3474691 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5688568 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13600596 USD
us-gaap Share Based Compensation
ShareBasedCompensation
956883 USD
us-gaap Share Based Compensation
ShareBasedCompensation
8258944 USD
CY2010Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
4500000 shares
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
41686066 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
34245189 USD
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638352 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54507838 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51638061 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54671403 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51638352 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51638061 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50422014 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
50879599 shares
siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-3802809 USD
siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
111801 USD
CY2011Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-2039851 USD
CY2012Q2 siga Change In Fair Value Of Common Stock Warrants
ChangeInFairValueOfCommonStockWarrants
-325012 USD
CY2012Q2 siga Common Stock Warrants Noncurrent Fair Value Disclosure
CommonStockWarrantsNoncurrentFairValueDisclosure
734739 USD
CY2011Q4 siga Common Stock Warrants Noncurrent Fair Value Disclosure
CommonStockWarrantsNoncurrentFairValueDisclosure
622938 USD
siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
111801 USD
siga Increase In Fair Value Of Warrants
IncreaseInFairValueOfWarrants
-3802809 USD
CY2012Q2 siga Minimum Period In Which Current Funds Is Sufficient To Cover Future Operations
MinimumPeriodInWhichCurrentFundsIsSufficientToCoverFutureOperations
P12M
siga Patent Preparation Fees
PatentPreparationFees
712618 USD
siga Payment Of Collateral For Commercial Surety Bond
PaymentOfCollateralForCommercialSuretyBond
0 USD
siga Payment Of Collateral For Commercial Surety Bond
PaymentOfCollateralForCommercialSuretyBond
1347956 USD
siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
3607398 USD
siga Proceeds From Issuance Of Warrants And Options
ProceedsFromIssuanceOfWarrantsAndOptions
1690 USD
siga Patent Preparation Fees
PatentPreparationFees
754875 USD
CY2012Q2 siga Patent Preparation Fees
PatentPreparationFees
376320 USD
siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
970816 USD
siga Reclass Of Common Stock Warrant Liability To Additional Paid In Capital Upon Exercise
ReclassOfCommonStockWarrantLiabilityToAdditionalPaidInCapitalUponExercise
0 USD
CY2011Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2491056 USD
siga Research And Development Revenue
ResearchAndDevelopmentRevenue
4166916 USD
siga Research And Development Revenue
ResearchAndDevelopmentRevenue
4187777 USD
CY2012Q2 siga Research And Development Revenue
ResearchAndDevelopmentRevenue
2701164 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2012Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51638352 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
SIGA TECHNOLOGIES INC
dei Trading Symbol
TradingSymbol
SIGA

Files In Submission

Name View Source Status
0001010086-12-000014-index-headers.html Edgar Link pending
0001010086-12-000014-index.html Edgar Link pending
0001010086-12-000014.txt Edgar Link pending
0001010086-12-000014-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20120630.xml Edgar Link completed
siga-20120630.xsd Edgar Link pending
siga-20120630x10q.htm Edgar Link pending
siga-20120630_cal.xml Edgar Link unprocessable
siga-20120630_def.xml Edgar Link unprocessable
siga-20120630_lab.xml Edgar Link unprocessable
siga-20120630_pre.xml Edgar Link unprocessable
siga-exhibit3112012q2.htm Edgar Link pending
siga-exhibit3122012q2.htm Edgar Link pending
siga-exhibit3212012q2.htm Edgar Link pending
siga-exhibit3222012q2.htm Edgar Link pending